Lincoln Pharmaceuticals has setup an Ultramodern State of Art unit for manufacturing Injectables. The Unit is manufacturing Liquid Injectables like Ampoules, Vials, Dry Powder Injectable and Liquid Syrup in this new facility. With an investment of nearly Rs 27 crore, the Company has set up an ultramodern state of art unit and aiming to get USFDA and MHRA certification.
With this new facility, the company is achieving Rs 50 crore additional turnovers during this financial year and bottom line will also improve accordingly. With this new facility, the company can produce all therapeutic medicines. Therefore, there is lot of opportunity to introduce the new product line and enter into new segment.Manufacturing facilities at Lincoln Pharmaceuticals are in accordance with WHO-GMP standards and ISO 9001 certification.
Lincoln Pharmaceutical is a Public Company with a large shareholder base. It has its own manufacturing facilities, covering all the major dosage forms like Tablets, Capsules, Injectables, Syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: